A bone-seeking clone exhibits different biological properties from the MDA-MB-231 parental human breast cancer cells and a brain-seeking clone in vivo and in vitro

Journal of Bone and Mineral Research

Volumn 16, Issue 8, 2001, Pages 1486-1495

  Yoneda, Toshiyuki ^a   Williams, Paul J ^a   Hiraga, Toru ^b   Niewolna, Maria ^a   Nishimura, Riko ^b  

^a University of Texas Health Science Center   (United States)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Bone metastasis; Breast cancer; Insulin like growth factor; Parathyroid hormone related protein; Transforming growth factor

Indexed keywords

PARATHYROID HORMONE RELATED PROTEIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA;

ADRENAL METASTASIS; ANIMAL MODEL; ARTICLE; BONE METASTASIS; BRAIN METASTASIS; BREAST CANCER; CANCER CELL; CARCINOGENICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; OSTEOLYSIS; OVARY METASTASIS;

AGAR; ANIMALS; BONE AND BONES; BONE NEOPLASMS; BRAIN; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL ADHESION; CELL CULTURE TECHNIQUES; CELL DIVISION; CHEMOTAXIS; CLONE CELLS; FEMALE; GENE EXPRESSION; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, NUDE; NEOPLASMS, EXPERIMENTAL; PARATHYROID HORMONE-RELATED PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROMOTER REGIONS (GENETICS); PROTEIN BIOSYNTHESIS; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0034912833     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.2001.16.8.1486     Document Type: Article

References (48)

1. Breast cancer
2. Recent trends in U.S. breast cancer incidence, survival, and mortality rates
3. Bone metastases in breast cancer, prostate cancer and myeloma
4. Bone metastases: Pathophysiology and management policy
5. Comments on hematogenous metastasis patterns in human as revealed by autopsy
6. The clinical course of bone metastases from breast cancer
7. Facilitation and suppression of bone metastasis
8. Modulation of the organ microenvironment for treatment of cancer metastasis
9. Localization of parathyroid hormone-related protein in breast cancer metastases: Increased incidence in bone compared with other sites
10. TGFβ signaling blockade inhibits PTH-rP secretion by breast cancer cells and bone metastases development
11. PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon tumours
12. An estrogen receptor mutant with strong hormone-independent activity from a metastatic breast cancer
13. Breast tumor cell lines from pleural effusions
14. Osteolytic bone metastasis in breast cancer
15. Arterial microvascularization and breast cancer colonization in bone
16. Cellular and molecular mechanisms of breast and prostate cancer metastasis to bone
17. Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis
18. Cloning of a TGFβ type I receptor that forms a heteromeric complex with the TGFβ type II receptor
19. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells
20. Smad5 and DPC4 are key molecules in mediating BMP-2-induced osteoblastic differentiation of the pluripotent mesenchymal precursor cell line C2C12
21. MCF-7: The first hormone-responsive breast cancer cell line
22. Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice
23. E-cadherin expression in human breast cancer cells suppress the development of osteolytic bone metastases in an experimental metastasis model
24. Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2
25. A simple method which allows simultaneous isolation of specific types of cells
26. Partnership between DPC4 and SMAD proteins in TGF-beta signaling pathways
27. Growth factors in bone matrix
28. Cooperative binding of Smad proteins to two adjacent DNA elements in the plasminogen activator inhibitor-1 promoter mediates transforming growth factor β-induced Smad-dependent transcriptional activation
29. Can't get no SMADisfaction: Smad proteins as positive and negative regulators of TGFβ family signals
30. Smad6 inhibits signaling by the TGF-β superfamily
31. Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor
32. Identification of Smad7, a TGFβ-inducible antagonist of TGFβ signaling
33. The MAD-related protein Smad7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling
34. The IGF-I receptor in cell growth, transformation and apoptosis
35. Why do cancer cells metastasize into particular organs
36. How cancer spreads
37. Bisphosphonates and prostate carcinoma
38. The distribution of secondary growths in cancer of the breast
39. Modulation of transforming growth factorβ activity in bone cultures by osteotropic hormones
40. Transforming growth factor-β: The breaking open of a black box
41. A mechanism of repression of TGFβ/Smad signaling by oncogenic Ras
42. The Ski oncoprotein interacts with the Smad proteins to repress TGFβ signaling
43. Silencing of TGFβ signaling by the pseudoreceptor BAMBI
44. Negative feedback regulation of TGFβ signaling by the SnoN oncoprotein
45. TGFβ signaling in growth control, cancer, and heritable disorders
46. Role of insulin-like growth factor family in cancer development and progression
47. Insulin-resistant MDA-MB231 human breast cancer cells contain a tyrosine kinase inhibiting activity
48. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity